- Condition: Blood Coagulation Disorders
Intervention: Drug: Dabigatran Etexilate 110 mg
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; Capital Health, Canada; Dalhousie University; Université de Montréal
Not yet recruiting - verified April 2012 - Condition: Drug Mechanism
Intervention: Drug: Lithium Carbonate
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Not yet recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention: Behavioral: Exercise
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Not yet recruiting - verified February 2012 - Conditions: Pregnancy; Microcirculation
Intervention:
Sponsors: IWK Health Centre; IWK Health Centre
Completed - verified January 2012 - Conditions: Streptococcal Infection; Gram-positive Bacterial Infection; Bacterial Infection
Interventions: Biological: Group B streptococcus vaccine; Biological: Placebo
Sponsors: Novartis; Novartis; Novartis Vaccines
Recruiting - verified May 2012 - Condition: Influenza
Interventions: Biological: High Dose Trivalent Inactivated Influenza Vaccine; Biological: Trivalent Inactivated Influenza Vaccine
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Active, not recruiting - verified February 2012 - Conditions: Meningococcal Disease; Meningococcal Meningitis
Intervention: Biological: Serogroup B meningococcal vaccine
Sponsors: Novartis; Novartis; Novartis Vaccines
Completed - verified January 2012 - Condition: Osteochondritis Dissecans of Ankle and Joints of Foot
Intervention: Other: Weight-Bearing as Tolerated
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Not yet recruiting - verified July 2011 - Conditions: Oppositional Defiant Disorder; Behaviour Disorder
Intervention: Behavioral: Strongest Families Intervention (formerly Family Help)
Sponsors: IWK Health Centre; IWK Health Centre; Canadian Institutes of Health Research (CIHR)
Recruiting - verified November 2011 - Condition: Malignant Lymphoma, Stem Cell Type
Interventions: Drug: Plerixafor (Mozobil); Drug: Plerixafor + G-CSF
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; Genzyme
Not yet recruiting - verified July 2011 - Condition: Vaccine Exposure During Pregnancy
Intervention:
Sponsors: Dalhousie University; Dalhousie University; Li Ka Shing Foundation; PHAC/CIHR Influenza Research Network
Active, not recruiting - verified June 2011 - Condition: Physical Activity
Interventions: Behavioral: Transformational Teaching; Behavioral: Standard Educational Practices
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified January 2012 - Condition: Influenza Vaccine
Interventions: Biological: Agriflu; Biological: Fluad; Biological: Intanza; Biological: Vaxigrip
Sponsors: University of British Columbia; University of British Columbia; PHAC/CIHR Influenza Research Network
Active, not recruiting - verified March 2012 - Condition: Physical Activity
Intervention: Behavioral: Exercise Videogame Bikes
Sponsors: University of Victoria; University of Victoria; Canadian Cancer Society; University of British Columbia; Dalhousie University; University of Auckland, New Zealand
Recruiting - verified June 2011 - Conditions: Psychotic Disorders; Schizophrenia
Intervention: Other: skin test
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Recruiting - verified December 2011 - Condition: Influenza
Intervention:
Sponsors: Dalhousie University; Dalhousie University; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified June 2011 - Condition: Postoperative Pain
Interventions: Drug: Saline placebo; Drug: Ropivicaine
Sponsors: IWK Health Centre; IWK Health Centre
Completed - verified July 2009 - Condition: Influenza
Interventions: Biological: Intanza; Biological: Intanza
Sponsors: Dalhousie University; Dalhousie University; IWK Health Centre; Sanofi Pasteur MSD; Mount Sinai Hospital, Canada
Completed - verified June 2011 - Conditions: Influenza, Human; Seasonal Influenza
Interventions: Biological: Quadrivalent seasonal influenza vaccine GSK2282512A; Biological: Fluarix®; Biological: Fluarix-YB; Biological: Quadrivalent seasonal influenza vaccine GSK2282512A
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified August 2011 - Conditions: Human Papillomavirus (HPV) Type 16/18 Infections; Cervical Neoplasia
Intervention: Biological: GSK580299 (Cervarix™)
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified February 2012 - Condition: Seasonal Influenza
Intervention: Biological: Fluviral
Sponsors: Dalhousie University; Dalhousie University; IWK Health Centre; Canadian Institutes of Health Research (CIHR); GlaxoSmithKline
Completed - verified June 2011 - Condition: Meningococcal Infections
Interventions: Biological: Meningococcal vaccine GSK 134612; Biological: Menactra®
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified June 2011 - Condition: Herpes Zoster
Interventions: Biological: Herpes Zoster Vaccine GSK1437173A; Biological: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified April 2012 - Condition: Herpes Zoster
Interventions: Biological: Herpes Zoster Vaccine GSK1437173A; Biological: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified April 2012 - Condition: Alcohol Consumption
Interventions: Behavioral: Computer-based Personalized Assessment Feedback; Behavioral: Computer-based sham
Sponsors: University of Alberta; University of Alberta; Norlien Foundation; Women and Children's Health Research Institute, Canada
Recruiting - verified April 2012 - Condition: Colonoscopy
Intervention:
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Recruiting - verified May 2010 - Condition: Generalized Anxiety Disorder
Interventions: Drug: Duloxetine; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Cognition
Intervention: Drug: Niaspan
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Recruiting - verified November 2009 - Condition: Morbid Obesity
Interventions: Other: Patients with a BMI < 30 given Oseltamivir; Other: Patients with a BMI > 40 given Oseltamivir
Sponsors: IWK Health Centre; IWK Health Centre; Canadian Center for Vaccinology; Capital District Health Authority, Canada; Dalhousie University; Hoffmann-La Roche
Completed - verified August 2011 - Condition: Infant Immunizations
Intervention: Biological: Pediacel® and Infanrix™-IPV/Hib
Sponsors: Dalhousie University; Dalhousie University; IWK Health Centre; Sanofi Pasteur MSD
Completed - verified June 2011 - Condition: Influenza Infection
Interventions: Biological: GSK2340274A; Biological: GSK2340273A; Biological: Saline placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified June 2011 - Conditions: Influenza A Virus, H1N1 Subtype; Influenza Infection
Interventions: Biological: GSK2340274A; Biological: GSK2340273A; Biological: Seasonal trivalent influenza vaccine (TIV); Biological: Saline placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified December 2011 - Condition: Influenza Infection
Interventions: Biological: GSK2340274A; Biological: GSK2340273A
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified January 2012 - Condition: Meningococcal C Disease
Intervention: Biological: Neisvac-C (Meningococcal C Conjugate Vaccine)
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified March 2012 - Conditions: Gait; Balance
Intervention:
Sponsors: Capital District Health Authority, Canada; Kim Parker
Recruiting - verified August 2011 - Condition: Low Back Pain
Intervention:
Sponsors: Capital District Health Authority, Canada; Mary Lynch
Active, not recruiting - verified October 2011 - Conditions: Smoking Cessation; Insurance Coverage
Interventions: Other: Full Smoking Cessation Treatment Coverage (100%); Other: No Smoking Cessation Treatment Coverage (0%)
Sponsors: Pfizer; Pfizer
Completed - verified February 2012 - Conditions: Triage; Pediatrics
Intervention:
Sponsors: St. Justine's Hospital; St. Justine's Hospital; SickKids Foundation; Canadian Institutes of Health Research (CIHR)
Completed - verified July 2011 - Condition: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Intervention: Biological: GSK580299, GSK Biological's HPV vaccine
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified April 2012 - Condition: Postoperative Pain
Interventions: Drug: Placebo; Drug: Pregabalin 150 mg
Sponsors: IWK Health Centre; IWK Health Centre
Recruiting - verified July 2011 - Conditions: Postoperative Pain; Opioid Use
Interventions: Drug: Pregabalin; Drug: Placebo
Sponsors: IWK Health Centre; IWK Health Centre
Completed - verified November 2011 - Condition: Influenza Virus
Interventions: Biological: GSK Biologicals' influenza vaccine GSK1557482A; Biological: Vaxigrip
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified November 2011 - Condition: Obesity
Interventions: Drug: TTP435; Drug: Placebo
Sponsors: TransTech Pharma; TransTech Pharma
Completed - verified June 2011 - Condition: Contraception
Interventions: Drug: Qlaira (BAY86-5027, SH T00658ID); Drug: Ortho Tri Cyclen Lo
Sponsors: Bayer; Bayer
Completed - verified July 2011 - Conditions: Poliomyelitis; Haemophilus Influenzae Type b Disease; Hepatitis B; Diphtheria; Pertussis; Tetanus
Intervention: Biological: Infanrix™ hexa
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified August 2011 - Condition: Influenza Disease
Interventions: Biological: GSK Bio's influenza vaccine GSK2186877A; Biological: Fluarix TM
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified January 2012 - Condition: Influenza
Intervention: Biological: Inactivated Influenza Vaccine Trivalent Types A and B (Split Virion)
Sponsors: British Columbia Centre for Disease Control; British Columbia Centre for Disease Control
Completed - verified July 2011 - Condition: Retinoblastoma
Interventions: Genetic: DNA ploidy analysis; Genetic: DNA stability analysis; Genetic: Southern blotting; Genetic: genetic linkage analysis; Genetic: loss of heterozygosity analysis; Genetic: mutation analysis; Genetic: polymorphism analysis; Genetic: reverse transcriptase-polymerase chain reaction; Other: environmental carcinogenesis study; Other: questionnaire administration; Other: study of socioeconomic and demographic variables; Procedure: evaluation of cancer risk factors; Procedure: mutation carrier screening
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Acute Coronary Syndrome; Myocardial Infarction; Smoking
Interventions: Drug: Bupropion HCl ER; Drug: Placebo
Sponsors: McGill University; Mark Eisenberg; Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Quebec
Completed - verified May 2008 - Condition: Vasomotor Symptoms
Interventions: Drug: desvenlafaxine succinate (DVS) SR; Drug: Placebo
Sponsors: Pfizer; Pfizer
Completed - verified July 2011 - Condition: Meningococcal Infections
Interventions: Biological: MenACWY-CRM; Biological: MenACWY-CRM; Biological: Licensed meningococcal ACWY vaccine
Sponsors: Novartis; Novartis Vaccines
Completed - verified December 2011 - Conditions: Influenza Disease Caused by an Influenza A Virus; Influenza Vaccines
Interventions: Biological: GSK 1557484A; Biological: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified March 2011 - Conditions: Cervical Cancer; Papillomavirus Infection
Intervention: Biological: GSK Bio's HPV vaccine 580299 (Cervarix TM)
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified November 2011 - Conditions: Healthy; Wheelchair Users
Intervention: Behavioral: wheelchair skills training
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Terminated - verified July 2009 - Conditions: Rubella; Varicella; Mumps; Measles
Interventions: Biological: MeMuRu-OKA (study vac); Biological: MMR, Varicella vacc (control)
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified September 2011 - Condition: Prophylaxis for HPV Infections and Associated Cervical Neoplasia
Interventions: Biological: Cervarix; Biological: Placebo control
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified February 2012 - Conditions: Pulmonary Disease, Chronic Obstructive; Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Other: Novel endpoint determination
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified February 2012 - Condition: Respiratory Tract Infection
Interventions: Dietary Supplement: COLD-fX natural health product; Dietary Supplement: COLD-fX; Other: Placebo
Sponsors: Capital Health, Canada; Capital Health, Canada; Afexa Life Sciences Inc; IWK Health Centre; Sunnybrook Health Sciences Centre; Erasmus Medical Center; University of BC Gerontology & Diabetes Research
Completed - verified July 2011 - Conditions: Human Papillomavirus (HPV) Infection; Cervical Neoplasia
Interventions: Biological: Cervarix™; Biological: Havrix™-based investigational formulation
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified February 2012 - Condition: Leukemia
Interventions: Drug: asparaginase; Drug: busulfan; Drug: cyclophosphamide; Drug: cyclosporine; Drug: cytarabine; Drug: daunorubicin hydrochloride; Drug: etoposide; Drug: gemtuzumab ozogamicin; Drug: methotrexate; Drug: mitoxantrone hydrochloride; Procedure: allogeneic bone marrow transplantation
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Completed - verified November 2010 - Condition: Leukemia
Interventions: Biological: filgrastim; Drug: asparaginase; Drug: cyclophosphamide; Drug: cyclosporine; Drug: cytarabine; Drug: daunorubicin hydrochloride; Drug: dexamethasone; Drug: etoposide; Drug: ifosfamide; Drug: imatinib mesylate; Drug: leucovorin calcium; Drug: mercaptopurine; Drug: methotrexate; Drug: pegaspargase; Drug: vincristine sulfate; Procedure: allogeneic bone marrow transplantation; Procedure: peripheral blood stem cell transplantation; Procedure: umbilical cord blood transplantation; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Completed - verified November 2010
 |
Join Clinical Trials for Healthy Volunteers in Nova Scotia |
